To explore the in vivo MOA of B002T‐LP004, different transplantation tumor models were established to investigate the potential involvement of both the host and tumor tissue STING pathway in tumor suppression following B002T‐LP004 administration. This evidence concerns the gene STING1 and neoplasm.